GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Accumulated Depreciation

Kyverna Therapeutics (Kyverna Therapeutics) Accumulated Depreciation : $-2.73 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Kyverna Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Kyverna Therapeutics's quarterly accumulated depreciation increased from Sep. 2023 ($-2.26 Mil) to Dec. 2023 ($-2.49 Mil) and increased from Dec. 2023 ($-2.49 Mil) to Mar. 2024 ($-2.73 Mil).

Kyverna Therapeutics's annual accumulated depreciation increased from Dec. 2021 ($-0.84 Mil) to Dec. 2022 ($-1.62 Mil) and increased from Dec. 2022 ($-1.62 Mil) to Dec. 2023 ($-2.49 Mil).

Kyverna Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Kyverna Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyverna Therapeutics Accumulated Depreciation Chart

Kyverna Therapeutics Annual Data
Trend Dec21 Dec22 Dec23
Accumulated Depreciation
-0.84 -1.62 -2.49

Kyverna Therapeutics Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Accumulated Depreciation Get a 7-Day Free Trial -1.62 - -2.26 -2.49 -2.73

Kyverna Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Kyverna Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Kyverna Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyverna Therapeutics (Kyverna Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kyverna Therapeutics Inc (NAS:KYTX) » Definitions » Accumulated Depreciation
Comparable Companies
Traded in Other Exchanges
N/A
Address
5980 Horton Street, STE 550, Emeryville, CA, USA, 94608
Website
https://www.kyvernatx.com
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR.

Kyverna Therapeutics (Kyverna Therapeutics) Headlines

From GuruFocus

Kyverna Therapeutics Announces Pricing of Upsized Initial Public Offering

By PRNewswire • 02-12-2024